Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) has issued an announcement.
Jiangxi Rimag Group Co., Ltd. announced the successful launch of its first batch of datasets on the Shanghai Data Exchange, marking a significant milestone in medical data assetization. This development positions the company as a leader in the marketization of medical imaging data elements, enhancing its role in the Healthy China Strategy and promoting high-quality development with secure medical imaging data resources. The company’s self-developed platform, Rimag Cloud, supports a comprehensive technical system for data intelligence, showcasing its leading edge in providing high-quality training data for AI models.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. is a leading medical group in China, specializing in medical imaging. It operates a medical imaging platform offering diversified services across the entire medical imaging industry chain in China. The company provides imaging center services, imaging solution services, and Rimag Cloud services through its wholly-owned subsidiary, Beijing Rimag Medical Information Technology Co., Ltd.
YTD Price Performance: -70.07%
Average Trading Volume: 1,118,761
Technical Sentiment Signal: Strong Buy
Learn more about 2522 stock on TipRanks’ Stock Analysis page.